Chinese Academy of Medical Sciences COVID-19 vaccine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Vaccine description
Target disease SARS-CoV-2
Type Killed/Inactivated
Clinical data
Legal status
  • Emergency authorization: China [1]
Routes of
administration
Intramuscular
Identifiers
DrugBank DB15863

Lua error in package.lua at line 80: module 'strict' not found. Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: {{{1}}}), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences.[2][3]

Authorizations

     Full authorization      Emergency authorization

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

On 9 June 2021, The vaccine has been approved by the Chinese authorities.[1]

References

  1. 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
  2. Clinical trial number NCT04412538 for "Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
  3. Clinical trial number NCT04659239 for "The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov

External links


<templatestyles src="Asbox/styles.css"></templatestyles>

<templatestyles src="Asbox/styles.css"></templatestyles>